Performance evaluation of the latest fully automated hematology analyzers in a large, commercial laboratory setting: a 4-way, side-by-side study. Lab Hematol 2005;11(4):285–97., ,
Clinical Flow Cytometric Analysis of Neoplastic Hematolymphoid Cells; Approved Guideline, 2nd Edn. CLSI document H43-A2. Wayne, PA: Clinical and Laboratory Standards Institute; 2005., , et al.
Optimal number of reagents required to evaluate hematolymphoid neoplasias: results of an international consensus meeting. Cytometry. 2001;461(1):23–7., , , .
Nine-color and 10-color flow cytometry in the clinical laboratory. Arch Pathol Lab Med 2006;130(5):680–90.
A limited antibody panel can distinguish B-precursor acute lymphoblastic leukemia from normal B precursors with four-color flow cytometry: implications for residual disease detection. Leukemia 1999;13(4):558–67., , , .
Bethesda International Consensus recommendations on the flow cytometric immunophenotypic analysis of hematolymphoid neoplasia: medical indications. Cytometry B Clin Cytom 2007;72 Suppl. 1:S5–13., , et al. 2006
Immunophenotyping of acute leukemias and myelodysplastic syndromes. Cytometry A 2004;58(1):62–71., , , ,
High incidence of occult leptomeningeal disease detected by flow cytometry in newly diagnosed aggressive B-cell lymphomas at risk for central nervous system involvement: the role of flow cytometry versus cytology. Blood 2005;105(2):496–502., , et al.
Contribution of flow cytometry to the diagnosis of gastric lymphomas in endoscopic biopsy specimens. Mod Pathol 1997;10(7):650–6., , , .
Primary diagnosis and REAL/WHO classification of non-Hodgkin's lymphoma by fine-needle aspiration: cytomorphologic and immunophenotypic approach. Diagn Cytopathol 2003;28(4):191–5., , et al.
Diagnostic utility of flow cytometric immunophenotyping in myelodysplastic syndrome. Blood 2001;98(4):979–87., , et al.
The utility of flow cytometric immunophenotyping in cytopenic patients with a non-diagnostic bone marrow: a prospective study. Leuk Res 2009;33(8):1039–46., , et al.
Definitions and standards in the diagnosis and treatment of the myelodysplastic syndromes: Consensus statements and report from a working conference. Leuk Res 2007;31(6):727–36., , et al.
Myeloid and monocytic dyspoiesis as determined by flow cytometric scoring in myelodysplastic syndrome correlates with the IPSS and with outcome after hematopoietic stem cell transplantation. Blood 2003;102(1):394–403., , et al.
Clinical utility of flow cytometry in the chronic lymphoid leukemias. Semin Oncol 1998;25(1):6–10., .
Circulating plasma cells detected by flow cytometry as a predictor of survival in 302 patients with newly diagnosed multiple myeloma. Blood 2005;106(7):2276–9., , et al.
Immunophenotypic characterization of plasma cells from monoclonal gammopathy of undetermined significance patients. Implications for the differential diagnosis between MGUS and multiple myeloma. Am J Pathol 1998;152(6):1655–65., , et al.
Bone marrow staging of patients with non-Hodgkin lymphoma by flow cytometry: correlation with morphology. Cancer 2000;88(4):894–9., , , .
Clinical significance of CD38 expression in chronic lymphocytic leukemia. Blood 2001;98(9):2633–9., , et al.
ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profile. Blood 2003;101(12):4944–51., , et al.
Prognostic significance of fluorescence intensity of surface marker expression in childhood B-precursor acute lymphoblastic leukemia. A Pediatric Oncology Group Study. Blood 1997;89(11):3960–6., , et al.
Variable CD52 expression in mature T cell and NK cell malignancies: implications for alemtuzumab therapy. Br J Haematol 2009;145(2):173–9., , et al.
Level of CD20-expression and efficacy of rituximab treatment in patients with resistant or relapsing B-cell prolymphocytic leukemia and B-cell chronic lymphocytic leukemia. Leukemia Lymphoma 2002;43(1):149–51., , , , .
Clinical importance of minimal residual disease in childhood acute lymphoblastic leukemia. Blood 2000;96(8):2691–6., , et al.
Quantitation of minimal disease levels in chronic lymphocytic leukemia using a sensitive flow cytometric assay improves the prediction of outcome and can be used to optimize therapy. Blood 2001;98(1):29–35., , et al.
2008;Chapter 6:Unit 6.25., , et al. Flow cytometric immunophenotyping of cerebrospinal fluid. Curr Protoc Cytom
Bethesda International Consensus recommendations on the immunophenotypic analysis of hematolymphoid neoplasia by flow cytometry: optimal reagents and reporting for the flow cytometric diagnosis of hematopoietic neoplasia. Cytom B Clin Cytom 2007;72 Suppl. 1:S14–22., , et al. 2006
Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. (ed.). Lyon: IARC Press; 2001., , ,
Flow cytometry in the diagnosis of acute leukemia. Semin Hematol 2001;38(2):124–38., .
Surface antigen phenotype can predict TEL-AML1 rearrangement in childhood B-precursor ALL: a Pediatric Oncology Group study. Leukemia 1998;12(11):1764–70., , , ,
Quantitative multiparametric immunophenotyping in acute lymphoblastic leukemia: correlation with specific genotype. I. ETV6/AML1 ALLs identification. Leukemia 2000;14(7):1225–31., , et al.
CD58 expression decreases as nonmalignant B cells mature in bone marrow and is frequently overexpressed in adult and pediatric precursor B-cell acute lymphoblastic leukemia. Am J Clin Pathol 2005;123(1):119–24., , .
Hematogones in the bone marrow of adults. Immunophenotypic features, clinical settings and differential diagnosis. Am J Clin Pathol 1994;102:202–11., , .
Comprehensive review of adult acute myelogenous leukemia: cytomorphological, enzyme cytochemical, flow cytometric immunophenotypic, and cytogenetic findings. J Clin Lab Analysis 1999;13(1):19–26..
Flow cytometry in the differential diagnosis of lymphocyte-rich thymoma from precursor T-cell acute lymphoblastic leukemia/lymphoblastic lymphoma. Am J Clin Pathol 2004;121(2):268–74., , , .
Flow cytometry in the diagnosis of mediastinal tumors with emphasis on differentiating thymocytes from precursor T-lymphoblastic lymphoma/leukemia. Leukemia Lymphoma 2004;45(3):529–38., , et al.
Complete remissions observed in acute myeloid leukemia following prolonged exposure to lintuzumab: a phase 1 trial. Leukemia Lymphoma 2009; 50:1336–44., , et al.
Distinctive immunophenotypic features of t(8;21)(q22;q22) acute myeloblastic leukemia in children. Blood 1992;80(12):3182–8., , et al.
Expression of the neural cell adhesion molecule CD56 is associated with short remission duration and survival in acute myeloid leukemia with t(8;21)(q22;q22). Blood 1997;90(4):1643–8., , et al.
Phenotypical characteristics of acute myelocytic leukemia associated with the t(8;21)(q22;q22) chromosomal abnormality: frequent expression of immature B-cell antigen CD19 together with stem cell antigen CD34. Blood 1992;80(2):470–7., , et al.
The flow cytometric pattern of CD34, CD15 and CD13 expression in acute myeloblastic leukemia is highly characteristic of the presence of PML-RAR alpha gene rearrangements. Haematologica 1999;84(5):405–12., , et al.
Expression of CD2 in acute promyelocytic leukemia correlates with short form of PML-RARalpha transcripts and poorer prognosis. Am J Clin Pathol 2004;121(3):402–7., , et al.
Using 4-color flow cytometry to identify abnormal myeloid populations. Arch Pathol Lab Med 2003;127(9):1140–7.,
Four-color flow cytometry identifies virtually all cytogenetically abnormal bone marrow samples in the workup of non-CML myeloproliferative disorders. Am J Clin Pathol 2003;120(6):854–65., .
Flow Cytometry in Clinical Diagnosis, 4th edn. Chicago: ASCP Press; 2006: 129–67., . Flow cytometric analysis in the diagnosis and prognosis of lymphoma and chronic leukemias. In , , (eds.),
Flow cytometric analysis of kappa and lambda light chain expression in evaluation of specimens for B-cell neoplasia. Cytometry 1996;26:243–52., , , .
Prominent clonal B-cell populations identified by flow cytometry in histologically reactive lymphoid proliferations. Am J Clin Pathol 2004;121:464–72., , , .
Diagnostic criteria for monoclonal B-cell lymphocytosis. Br J Haematol 2005;130:325–32., , et al.
Monoclonal B lymphocytes with the characteristics of indolent chronic lymphocytic leukemia are present in 3.5% of adults with normal blood counts. Blood 2002;100:635–9., , et al.
The cell-surface antigen and DNA content distribution of lymph-nodes with reactive hyperplasia. Modern Pathol 1995;8(5):536–43., , , .
Diagnostic usefulness of aberrant CD22 expression in differentiating neoplastic cells of B-cell chronic lymphoproliferative disorders from admixed benign B cells in four-color multiparameter flow cytometry. Am J Clin Pathol 2005;123:826–32., , et al.
Lack of expression of surface immunoglobulin light chains in B-cell non-Hodgkin lymphomas. Am J Clin Pathol 2000;113(3):399–405., , , .
Lack of surface immunoglobulin light chain expression by flow cytometric immunophenotyping can help diagnose peripheral B cell lymphoma. Am J Clin Pathol 2002;118:229–34., , .
Follicular lymphoma can be distinguished from benign follicular hyperplasia by flow cytometry using simultaneous staining of cytoplasmic bcl-2 and cell surface CD20. Am J Clin Pathol 2000;114(2):258–63., , et al.
CD10 expression in follicular lymphoma and large cell lymphoma is different from that of reactive lymph node follicles. Archives Pathol Lab Med 1998;122(6):539–44., , .
HLA-DO – A useful marker to distinguish florid follicular hyperplasia from follicular lymphoma by flow cytometry. Am J Clin Pathol 2003;119(6):842–51., , .
Levels of expression of CD19 and CD20 in chronic B cell leukaemias. J Clin Pathol 1998; 51:364–9., , , , .
Diminished expression of CD19 in B-cell lymphomas. Cytom B Clin Cytom 2005;63B:28–35., , et al.
CD2 is expressed by a sub-population of normal B cells and is frequently present in mature B-Cell neoplasms. Clin Cytom 2002;50:243–8., , et al.
Aberrant expression of T-cell-associated antigens on B-cell non-Hodgkin lymphoma. Am J Clin Pathol 2001;115:396–403., , .
Loss of CD20 expression following treatment with rituximab (chimaeric monoclonal anti-CD-20): a retrospective cohort analysis. Br J Haematol 2001;114:881–3., , et al.
Report of the European Myeloma Network on multiparametric flow cytometry in multiple myeloma and related disorders. Haematologica 2008;93(3):431–8., , et al.
Immunophenotypic characterization of plasma cells from monoclonal gammopathy of undetermined significance patients. Implications for the differential diagnosis between MGUS and multiple myeloma. Am J Pathol 1998;152:1655–65., , et al.
High-sensitive immunophenotyping and DNA ploidy studies for the investigation of minimal residual disease in multiple myeloma. Br J Haematol 1999;107:121–31., , et al.
Immunophenotypic profile of lymphoplasmacytic lymphoma/Waldenström macroglobulinemia. Am J Clin Pathol 2005;124:414–20., , , , .
Flow cytometric immunophenotypic analysis of 306 cases of multiple myeloma. Am J Clin Pathol 2004;121:482–8., , , .
Flow cytometric disease monitoring in multiple myeloma: the relationship between normal and neoplastic plasma cells predicts outcome after transplantation. Blood 2002;100(9):3095–100., , et al.
Prognostic value of immunophenotyping in multiple myeloma: a study by the PETHEMA/GEM cooperative study groups on patients uniformly treated with high-dose therapy. J Clin Oncol 2008;26(16):2737–44., , et al.
An approach to diagnosis of T-cell lymphoproliferative disorders by flow cytometry. Clinical Cytometry 2002;50B:177–90., , et al.
Artifactual staining of monoclonal antibodies in two-color combinations is due to an immunoglobulin in the serum and plasma. Cytometry 1994;18(3):140–6., , et al.
Increased peripheral blood gamma delta T-cells in patients with lymphoid neoplasia: A diagnostic dilemma in flow cytometry. Cytometry 1999;38(6):280–5., ,
Immunophenotype and TCR-V beta repertoire of peripheral blood T-cells in acute infectious mononucleosis. Blood Cells Molecules Diseases 2003;10:1–12., , et al.
Immunophenotypic analysis of peripheral T-cell neoplasms. A multiparameter flow cytometric approach. Am J Clin Pathol 2001;116:512–26., , et al.
Diminished CD3 expression is useful for detecting and enumerating Sézary cells. Am J Clin Pathol 2000;114(3):467–77., .
Flow cytometric immunophenotyping of adult T-cell leukemia/lymphoma using CD3 gating. Am J Clin Pathol 2005;124(2):199–204., , et al.
Flow-cytometric assessment of T-cell clonality in clinical specimens. LabMed 2007;38(8):477–82., , .
Flow cytometric analysis of the V beta repertoire in healthy controls. Cytometry 2000;40(4):336–45., , et al.
Monitoring the decrease of circulating malignant T cells in cutaneous T-cell lymphoma during photopheresis and interferon therapy. Archives of Dermatology 2003;139(7):909–13., , , .
A comparison of morphologic features, flow cytometry, TCR-V-beta analysis, and TCR-PCR in qualitative and quantitative assessment of peripheral blood involvement by Sezary syndrome. Am J Clin Pathol 2006;125(3):364–74., , et al.
Clinicobiological, immunophenotypic, and molecular characteristics of monoclonal CD56-/+dim chronic natural killer cell large granular lymphocytosis. Am J Pathol 2004;165(4):1117–27., , et al.
Complex expression of natural killer receptor genes in single natural killer cells. Immunology 2002;106(3):373–80., , , .
Dysregulated NK receptor expression in patients with lymphoproliferative disease of granular lymphocytes. Blood 2004;103(9):3431–9., , et al.
Comparative analysis of NK cell subset distribution in normal and lymphoproliferative disease of granular lymphocyte conditions. European J Immunol 2004;34(10):2930–40., , et al.
NK-cell repertoire is feasible for diagnosing Epstein-Barr virus-infected NK-cell lymphoproliferative disease and evaluating the treatment effect. Am J Hematol 2006;81(8):576–81., , et al.
Four-color flow cytometry shows strong concordance with bone marrow morphology and cytogenetics in the evaluation for myelodysplasia. Am J Clin Pathol 2005;124(2):170–81., , et al.
Immunophenotypic clustering of myelodysplastic syndromes. Blood 2002;100(7):2349–56., , et al.